Neonatal newborn hearing screening: four years' experience at Ferrara University Hospital (CHEAP project): part 1. Acta Otorhinolaryngol Ital. 2007 Feb;27(1):10-6.
Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model Acta Otorhinolaryngol Ital. 2006 Jun;26(3):133-9. Download PDF File (86 k)
Noise-induced hearing loss: a study on the pharmacological protection in the Sprague Dawley rat with N-acetyl-cysteine. Acta Otorhinolaryngol Ital. 2006 Jun;26(3):133-9. Download PDF File (220 k)
Electrophysiological findings in the Sprague-Dawley rat induced by moderate-dose carboplatin. Hear Res. 2003 Aug;182(1-2):48-55. Download PDF File (333 k)
Hearing loss evaluation of Sjogren's syndrome using distortion product otoacoustic emissions. Acta Otolaryngol Suppl. 2002;(548):20-5. Download PDF File (319 k)
Ototoxic effects of cisplatin in a Sprague-Dawley rat animal model as revealed by ABR and transiently evoked otoacoustic emission measurements. Hear Res. 2002 Aug;170(1-2):70. Download PDF File (490 k)
Correlations between risk factors for hearing impairment and TEOAE screening test outcome in neonates at risk for hearing loss. Scand Audiol Suppl. 2001;(52):15-7.
Comparison of neonatal transient evoked otoacoustic emission responses recorded with linear and QuickScreen protocols. Audiology. 2000 Mar-Apr;39(2):70-9.
Optimization of TEOAE recording protocols: a linear protocol derived from parameters of a time-frequency analysis: a pilot study on neonatal subjects. Scand Audiol. 2000;29(1):21-7.
[Evaluation of a linear TEOAE protocol in hearing screening of neonates: feasibility study]. Acta Otorhinolaryngol Ital. 1998 Aug;18(4):213-7. Italian.